Immunobiological activities of a chemically synthesized lipid A of Porphyromonas gingivalis.
暂无分享,去创建一个
T. Ogawa | H. Shimauchi | Y. Asai | H. Yamamoto | K. Ochiai | S. Niwata | T. Kodama | T. Jinno | Y. Taiji
[1] T. Ogawa,et al. Prevention of endotoxin-induced lethality in mice by calmodulin kinase activator. , 2000, FEMS immunology and medical microbiology.
[2] K. Tanamoto. Induction of Lethal Shock and Tolerance by Porphyromonas gingivalis Lipopolysaccharide ind-Galactosamine-Sensitized C3H/HeJ Mice , 1999, Infection and Immunity.
[3] T. Kirikae,et al. Lipopolysaccharides (LPS) of Oral Black-Pigmented Bacteria Induce Tumor Necrosis Factor Production by LPS-Refractory C3H/HeJ Macrophages in a Way Different from That of Salmonella LPS , 1999, Infection and Immunity.
[4] S. Goyert,et al. Lipopolysaccharide structure influences the macrophage response via CD14-independent and CD14-dependent pathways. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[5] K. Tanamoto,et al. The lipid A moiety of Porphyromonas gingivalis lipopolysaccharide specifically mediates the activation of C3H/HeJ mice. , 1997, Journal of immunology.
[6] A. Kinoshita,et al. Antagonistic effect of synthetic peptides corresponding to the binding regions within fimbrial subunit protein from Porphyromonas gingivalis to human gingival fibroblasts. , 1997, Vaccine.
[7] T. Ogawa,et al. Stimulation of splenocytes in C3H/HeJ mice with Porphyromonas gingivalis lipid A in comparison with enterobacterial lipid A. , 1996, Immunobiology.
[8] T. Ogawa,et al. Immunopharmacological activities of the nontoxic monophosphoryl lipid A of Porphyromonas gingivalis. , 1996, Vaccine.
[9] C. Manthey,et al. Elimination of trace endotoxin protein from rough chemotype LPS , 1994 .
[10] T. Ogawa. Immunobiological properties of chemically defined lipid A from lipopolysaccharide of Porphyromonas (Bacteroides) gingivalis. , 1994, European journal of biochemistry.
[11] T. Ogawa. Chemical structure of lipid A from porphyromonas (bacteroides) gingivalis lipopolysaccharide , 1993, FEBS letters.
[12] N. Skaug,et al. Stimulation of B lymphocytes by lipopolysaccharides from anaerobic bacteria. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[13] M. Tamura,et al. Lipopolysaccharides of Bacteroides intermedius (Prevotella intermedia) and Bacteroides (Porphyromonas) gingivalis Induce Interleukin-8 Gene Expression in Human Gingival Fibroblast Cultures , 1993, Infection and immunity.
[14] S. Nagaoka,et al. Lipopolysaccharides of Bacteroides intermedius (Prevotella intermedia) and Bacteroides (Porphyromonas) gingivalis induce interleukin-8 gene expression in human gingival fibroblast cultures , 1992 .
[15] T. Ogawa,et al. Immunobiological activities of synthetic peptide segments of fimbrial protein from Porphyromonas gingivalis. , 1991, Biochemical and biophysical research communications.
[16] M. Caron,et al. Structure-Function Relationships , 1991 .
[17] T. Ogawa,et al. Lipopolysaccharides of oral anaerobes associated with chronic inflammation: chemical and immunomodulating properties. , 1990, International reviews of immunology.
[18] A. Weintraub,et al. Structural characterization of the lipid A component of Bacteroides fragilis strain NCTC 9343 lipopolysaccharide. , 1989, European journal of biochemistry.
[19] Takashi Matsumoto,et al. An improved procedure for metallocene-promoted glycosidation. Enhanced reactivity by employing 1:2-ratio of Cp2HfCl2-AgClO4 , 1989 .
[20] I. Olsen,et al. Fatty acids and sugars in lipoplysaccharides from Bacteroides intermedius. Bacteroides gingivalis and Bacteroides loescheii. , 1988, Oral microbiology and immunology.
[21] M. Listgarten,et al. Bacteroides gingivalis, Bacteroides intermedius and Actinobacillus actinomycetemcomitans in human periodontal diseases. , 1988, Journal of clinical periodontology.
[22] T. Kato,et al. Hemagglutinating activity of lipopolysaccharides from subgingival plaque bacteria , 1987, Infection and immunity.
[23] H. Okamura,et al. Low endotoxic activities of synthetic Salmonella-type lipid A with an additional acyloxyacyl group on the 2-amino group of beta (1-6) glucosamine disaccharide 1,4'-bisphosphate , 1986, Infection and immunity.
[24] T. Kirikae,et al. Hemagglutination Induced by Lipopolysaccharides and Lipid A , 1986, Microbiology and immunology.
[25] S. Kusumoto,et al. Total synthesis of escherichia coli lipid A , 1985 .
[26] T. Ogawa,et al. Immunopharmacological activities of a synthetic counterpart of a biosynthetic lipid A precursor molecule and of its analogs , 1985, Infection and immunity.
[27] E. Rietschel,et al. Chemical structure of Escherichia coli lipid A , 1985 .
[28] M. Hayashi,et al. Glycosylation using glucopyranosyl fluorides and silicon-based catalysts. Solvent dependency of the stereoselection , 1984 .
[29] S. Kusumoto,et al. Total Synthesis of Lipid A, Active Principle of Bacterial Endotoxin , 1984 .
[30] S. Kusumoto,et al. Synthetic approach to lipid A: Preparation of phosphorylated disaccharides containing (R)-3-hydroxyacyl and (R)-3-acyloxyacyl groups , 1983 .
[31] K. Joiner,et al. Lipopolysaccharides from Bacteroides fragilis are mitogenic for spleen cells from endotoxin responder and nonresponder mice , 1982, Infection and immunity.
[32] W. Reutter,et al. Galactosamine-induced sensitization to the lethal effects of endotoxin. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[33] D. Morrison,et al. Binding of polymyxin B to the lipid A portion of bacterial lipopolysaccharides. , 1976, Immunochemistry.
[34] Schoffstall. Cyclopropylmethyl dihydrogen phosphate. Preparation and use in the phosphorylation of nucleosides. , 1975, The Journal of organic chemistry.
[35] J. Dittmer,et al. A SIMPLE, SPECIFIC SPRAY FOR THE DETECTION OF PHOSPHOLIPIDS ON THIN-LAYER CHROMATOGRAMS. , 1964, Journal of lipid research.
[36] H. Dörfel,et al. Die quantitative Bestimmung reduzierender Zucker auf Papierchromatogrammen , 1954 .